The 3rd Science and Technology Plan (FY2006-FY2010) emphasizes that science and technology include “bioethical issues, including human cloning technology; anxiety about genetically engineered foods; concerns about the misuse of personal information; and ethical issues for researchers, including those who forge experimental data” and responsible measures should be taken to resolve these issues. In 2007, the Department of Public Policy was created at the Institute of Medical Science, the University of Tokyo (IMSUT). We explore how society deals with the social, legal, and ethical implications and find possible solution towards emerging issues in the future. We always keep in mind to consider the implications for the vulnerable and the challenged. Various studies are conducted to respond to the challenges by medical sciences and its transformation, by multidisciplinary approach such as medical ethics, medical sociology, law, STS, cultural anthropology, policy science, disability studies and epidemiology.
- 【Paper Publication Announcement】 Informed consent in clinical trials using stem cells: Suggestions and points of attention from informed consent training workshops in Japan (M Kusunose, F Nagamura, K Muto)
- Public attitudes to the promotion of genomic crop studies in Japan
- Children and the Genetic Identification of Talent
- Our paper has been selected for highlighting on the A-IMBN Research web
- The first paper on consent and communication of Biobank Japan participants
- Living liver transplantation in Japan (Muto K)
Department of Public Policy, The Institute of Medical Science, The University of Tokyo